Neok Bio: Funding, Investors & Team (Sep 2026)
Neok Bio is a biotech startup that focuses on bispecific ADCs in cancer therapy.
Neok Bio has raised $75.0M across 1 funding round on record, the most recent a Series A of $75.0M announced in Nov 2025.
That round is above the $42M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Neok Bio Company Profile and Key Stats
Latest funding round on record: Nov 2025.
Neok Bio Funding Rounds
Neok Bio Founders and Leadership Team
Contact details for the Neok Bio team: 1 of 1 has an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →Neok Bio Funding Compared to Other Biotechnology Startups
Neok Bio's latest round of $75.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Neok Bio in Biotechnology and Palo Alto
Companies Similar to Neok Bio
Crystalys Therapeutics is a clinical-stage biopharmaceutical company transforming the treatment of gout.
Lifordi Immunotherapeutics is a biotech company that provides antibody-drug conjugates for autoimmune and…
Solve Therapeutics is a biopharmaceutical company that develops Antibody Drug Conjugate and Bispecific…
Artizan Biosciences focuses on drug discovery and development for diseases involving the human intestinal…
TORL BioTherapeutics is a clinical-stage biopharmaceutical business.
ThirdLaw Molecular pioneers revolutionary Spiroligomer™ molecules for safer, more targeted, effective disease…
Aerska is a biotechnology company that is creating RNA medications to treat, postpone, and prevent brain…
Weike Bio is a gene therapy drug development company.
Twinpig Biolab researches and develops anticancer drugs.
Kunshi Biotechnology is a drug developer with an emphasis on solid tumor cells.
BOOST Pharma develops a stem cell therapy for the treatment of osteogenesis imperfecta.
Step Pharma is a biotechnology company.
Neok Bio Funding FAQs
What does Neok Bio do?
Neok Bio is a biotech startup that focuses on bispecific ADCs in cancer therapy.
How much funding has Neok Bio raised?
Neok Bio has raised $75.0M across 1 round on record. The most recent is a Series A of $75.0M announced in Nov 2025.
When did Neok Bio last raise funding?
Neok Bio's most recent funding round on record is a Series A of $75.0M, announced in Nov 2025.
Where is Neok Bio headquartered?
Neok Bio is based in Palo Alto, United States.
How many employees does Neok Bio have?
Neok Bio is in the 1-10 employee band.
How does Neok Bio's funding compare to other Biotechnology startups?
Neok Bio's latest round of $75.0M is above the $42M median round size for Biotechnology companies on FundedIQ across 20 tracked companies over the last two years.
About FundedIQ's Neok Bio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Neok Bio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.